Skip to main content

Advertisement

Log in

Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experience

  • Radiotherapy
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Purpose

The aim of our study was to retrospectively evaluate the feasibility and clinical benefit of cyberknife stereotactic radiosurgery (CSRS) in patients treated at Florence University for recurrent, pre-irradiated brain lesions.

Materials and methods

Thirteen patients were retreated with cyberknife. Mean age was 47.1 years (range 33–77 years). Karnofsky performance status ranged from 60 to 100 (median 80). Eleven (84.6 %) out of 13 patients had metastatic lesions: four (36.4 %) had primary lung, three (27.2 %) had primary breast cancer and four (36.4 %) other types of solid malignancies. Two (15.4 %) out of 13 patients had recurrent of glioblastoma.

Results

In terms of compliance with CSRS, the majority of patients did not develop any acute side effects. However, two (15.4 %) out of 13 patients developed acute grade 2 toxicity requiring an increase of steroid medication. At the time of the last follow-up, response rates were as follows: complete response in one case (16.6 %), partial response in three (50 %) and stable disease in two (33.4 %).

Conclusions

Re-irradiation with CSRS is a feasible and effective option for pre-irradiated, recurrent brain lesions to obtain clinical benefit without excessive acute toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. Adv Neurol 19:579–592

    CAS  PubMed  Google Scholar 

  2. Rwigema JC, Wegner RE, Mintz AH et al (2011) Stereotactic radiosurgery to the resection cavity of brain metastases: a retrospective analysis and literature review. Stereotact Funct Neurosurg 89:329–337

    Article  PubMed  Google Scholar 

  3. Niibe Y, Hayakawa K (2010) Oligometastases and oligo-recurrence: the new era of cancer therapy. Jap J Clin Oncol 40:107–111

    Article  Google Scholar 

  4. Tsao MN, Lloyd NS, Wong RK et al (2005) Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 31:256–273

    Article  PubMed  Google Scholar 

  5. Sperduto PW, Chao ST, Sneed PK (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655–661

    Article  PubMed  Google Scholar 

  6. Aoyama H, Shirato H, Tago M (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491

    Article  CAS  PubMed  Google Scholar 

  7. Kocher M, Soffietti R, Abacioglu U (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141

    Article  PubMed Central  PubMed  Google Scholar 

  8. Brown PD, Brown CA, Pollock B et al (2002) Stereotactic radiosurgery for patients with “radioresistant” brain metastases. Neurosurgery 51:656–665

    PubMed  Google Scholar 

  9. Chang EL, Selek U, Hassenbusch SJ III et al (2005) Outcome variation among socalled “radioresistant” brain metastases treated with stereotactic radiosurgery. Neurosurgery 56:936–945

    PubMed  Google Scholar 

  10. Abusaris H, Storchi PR, Brandwijk RP, Nuyttens JJ (2011) Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields. Radiother Oncol 99:235–239

    Article  PubMed  Google Scholar 

  11. Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298

    Article  CAS  PubMed  Google Scholar 

  12. Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg 93(Suppl 3):219–222

    PubMed  Google Scholar 

  13. Nakamura JL, Verhey LJ, Smith V (2001) Dose conformity of gamma knife radiosurgery and risk factors for complications. Int J Radiat Oncol Biol Phys 51:1313–1319

    Article  CAS  PubMed  Google Scholar 

  14. MacDonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280

    CAS  PubMed  Google Scholar 

  15. Cooper JS, Steinfeld AD, Lerch IA (1999) Cerebral metastases: value of reirradiation in selected patients. Radiology 174:883–885

    Article  Google Scholar 

  16. Wong WW, Schild SE, Sawyer TE, Shaw EG (1996) Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34:585–590

    Article  CAS  PubMed  Google Scholar 

  17. Loeffler JS, Kooy HM, Wen PY et al (1990) The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 8:576–582

    CAS  PubMed  Google Scholar 

  18. Manning MA, Cardinale RM, Benedict SH et al (2000) Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 47:603–608

    Article  CAS  PubMed  Google Scholar 

  19. Chao ST, Barnett GH, Vogelbaum MA et al (2008) Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy. Cancer 113:2198–2204

    Article  PubMed  Google Scholar 

  20. Patel M, Siddiqui F, Jin JY et al (2009) Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 92:185–191

    Article  PubMed  Google Scholar 

  21. Auchter RM, Lamond JP, Alexander E et al (1996) A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35:27–35

    Article  CAS  PubMed  Google Scholar 

  22. Alexander E 3rd, Moriarty TM, Davis R et al (1995) Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87:34–40

    Article  PubMed  Google Scholar 

  23. Ma L, Petti P, Wang B et al (2011) Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg 114:1580–1584

    Article  PubMed  Google Scholar 

  24. Karam I, Nichol A, Woods R, Tyldesley S (2011) Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era. Radiat Oncol 28:181

    Article  Google Scholar 

  25. Ammirati M, Cobbs CS, Linskey ME et al (2010) The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:85–96

    Article  PubMed Central  PubMed  Google Scholar 

  26. Dritschilo A, Bruckman JE, Cassady JR, Belli JA (1981) Tolerance of brain to multiple courses of radiation therapy. I. Clinical experiences. Br J Radiol 54:782–786

    Article  CAS  PubMed  Google Scholar 

  27. Wong CS, Hao Y (1999) Long-term recovery kinetics of radiation damage in rat spinal cord. Int J Radiat Oncol Biol Phys 37:171–179

    Article  Google Scholar 

  28. Abusaris H, Storchi PR, Brandwijk RP, Nuyttens JJ (2011) Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields. Radiother Oncol 99:235–239

    Article  PubMed  Google Scholar 

  29. Gwak HS, Yoo HJ, Youn SM et al (2009) Radiosurgery for recurrent brain metastases after whole-brain radiotherapy: factors affecting radiation-induced neurological dysfunction. J Korean Neurosurg Soc 45:275–283

    Article  PubMed Central  PubMed  Google Scholar 

  30. Joseph J, Adler JR, Cox RS, Hancock SL (1996) Linear accelerator-based stereotaxic radiosurgery for brain metastases: the influence of number of lesions on survival. J Clin Oncol 14(4):1085–1092

    Google Scholar 

  31. Ernst-Stecken A, Ganslandt O, Lambrecht U et al (2007) Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 81:287–294

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Daniela Greto, Lorenzo Livi, Pierluigi Bonomo, Laura Masi, Beatrice Detti, Icro Meattini, Monica Mangoni, Raffaella Doro, Virginia Favuzza, Samantha Cipressi, Carmine Iermano, Ivano Bonucci, Mauro Loi and Gianpaolo Biti declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Greto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greto, D., Livi, L., Bonomo, P. et al. Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experience. Radiol med 119, 721–726 (2014). https://doi.org/10.1007/s11547-014-0383-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-014-0383-2

Keywords

Navigation